Telix Pharmaceuticals: Roadblocks Piling Up, But They're Not Insurmountable

Telix Pharmaceuticals Limited (NASDAQ: TLX ) has been in the news a fair bit recently. And I've remained positive despite the apparent setbacks that this company has faced. Today, let's contend with their latest round of bad news that hasI have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech companies. It is my passion to educate everyone possible on the science behind the businesses that we invest in, and it's my mission to help you do your due diligence and not get b ...